Skip to content
ZINOS
A modern Swiss hospital building below a mountain ridge at first light.

Run your trials inside your Swiss hospital.

How ZINOS fits the Human Research Act, the Clinical Trials Ordinance, and Swiss data protection law.

Trial approval in Switzerland.

Medicinal-product trials in categories B and C, and device trials in category C, also need Swissmedic authorisation.

  1. Protocol and dossier
  2. Ethics review via BASEC
  3. Swissmedic, where required
  4. Approvals received before start
  5. Trial conduct
  6. Results summary published
  7. ClinO: 20-year retention

Swiss rules, and how ZINOS fits.

  • 20-year ClinO retention: configurable retention and archival policy
  • Electronic consent, permitted since November 2024: eICF with signatures
  • Cantonal or federal data law: records stay under your controls

Where the record sits in Switzerland.

Under on-premise deployment, ethics committees and Swissmedic receive what the law requires, and the trial record stays on your servers.

  • Hospital information system
  • Laboratory system
  • Imaging and pathology
  • Identity and access
  • Site operating system
  • Data hub
  • Local AI node
  • Audit trail
Scoped access
  • Cantonal ethics committee
  • Swissmedic
  • Sponsor
  • Monitor

Swiss requirements, mapped to ZINOS.

RequirementRuleZINOS capability
Ethics approval before startHRA, ClinOApproval tracking in the site file
Swissmedic authorisationClinO B and C; ClinO-MD CVersioned, signed submission documents
Electronic consentClinO Art. 7cTablet eICF with audit trail
Retention of at least 20 yearsClinO Art. 45Configurable retention and archival
Data protectionRevised FADP or cantonal lawOn-premise deployment, configurable pseudonymisation
Each row states a design fact about ZINOS, not a compliance claim.
A modern Swiss hospital building below a mountain ridge at first light.

See ZINOS against Swiss rules.

Book a call on running trials in Switzerland, and bring your DPO.

Book a demo